Status:
UNKNOWN
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study
Lead Sponsor:
Malaria Consortium
Conditions:
Malaria
Eligibility:
All Genders
3-59 years
Phase:
PHASE4
Brief Summary
We describe a Type II hybrid effectiveness-implementation study design which evaluates the effects of a clinical intervention on relevant outcomes whilst collecting information on implementation. It i...
Detailed Description
This implementation research study uses a convergent mixed-methods approach. SMC will be implemented in four monthly cycles between December 2021 and February 2022. The research will involve the follo...
Eligibility Criteria
Inclusion
- Children aged 3-59 months living in a SMC eligible area in Lalua or Mercate district in Nampula province in Mozambique.
Exclusion
- Children with HIV,
- Children with a history of severe adverse reaction to SP or AQ, or
- children who had used SP within the previous month before recruitment
Key Trial Info
Start Date :
January 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2023
Estimated Enrollment :
3156 Patients enrolled
Trial Details
Trial ID
NCT05186363
Start Date
January 8 2022
End Date
December 1 2023
Last Update
November 2 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lalaua district
Nampula, Mozambique
2
Muecate District
Nampula, Mozambique